Lipocine's market cap is currently ―. The company's EPS TTM is $-3.147; its P/E ratio is -1.52; Lipocine is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.68. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ -3.12M	-	$ 55.00K	-	$ 0.00
Gross Profit	$ -3.12M	-	$ 55.00K	-	$ -2.10M
EBIT	$ -6.65M	$ -3.55M	$ -3.87M	$ -2.53M	$ -2.41M
EBITDA	$ -6.65M	$ -3.79M	$ -4.12M	$ -2.68M	$ -2.41M
Net Income Common Stockholders	$ -6.65M	$ -3.55M	$ 4.92M	$ -2.23M	$ -2.41M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 23.85M	$ 25.79M	$ 28.87M	$ 32.53M	$ 34.26M
Total Assets	$ 24.75M	$ 30.48M	$ 34.02M	$ 37.54M	$ 39.42M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -23.85M	$ -25.79M	$ -28.87M	$ -32.53M	$ -34.26M
Total Liabilities	$ 2.27M	$ 1.83M	$ 1.93M	$ 1.91M	$ 1.78M
Stockholders Equity	$ 22.48M	$ 28.66M	$ 32.09M	$ 35.63M	$ 37.65M
Cash Flow	-
Free Cash Flow	$ -2.61M	$ -3.31M	$ -3.93M	$ -1.94M	$ -3.20M
Operating Cash Flow	$ -2.61M	$ -3.31M	$ -3.93M	$ -1.84M	$ -3.20M
Investing Cash Flow	$ 1.24M	$ 3.56M	$ 5.55M	$ 2.60M	$ 613.90K
Financing Cash Flow	$ 421.08K	$ -5.20K	$ -6.02K	$ -5.90K	$ 44.00

Currency in USD

Lipocine Earnings and Revenue History

Income Statement >

Lipocine Debt to Assets

Balance Sheet >

Lipocine Cash Flow

Cash Flow >

Lipocine Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing